Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Why Track A Financial Index explains the value of benchmarks for performance evaluation, risk management, and strategy alignment.
24,720 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
A looming funding gap in Social Security invites tough questions for your retirement. This guide explains what insolv...
The Digital Chamber launches the Prediction Markets Working Group to win federal oversight for prediction markets, se...
A former francisco homeless charity chief faces nine felony counts after prosecutors allege more than $1.2 million in...
Debt service now approaches $1 trillion annually as the interest on the $38.8 trillion national debt climbs, squeezin...
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Investing in oil has a reputation for big moves and big headlines. This guide dives into vitesse energy stock your po...
Workday's Aneel Bhusri has reclaimed the CEO role and argues the 'vibe coding' threat to enterprise software is overs...
A major regulatory milestone changes how crypto assets are viewed in the U.S. This guide breaks down the new classifi...
This week, 180 leaders from business, government, nonprofits, academia, technology, and the arts converged for Brains...
The (feam) 2026 earnings call offers more than numbers. It reveals management’s strategy, how FEAM is navigating cost...
New data highlights a tougher entry to the workforce for Gen Z graduates compared with Millennials, with a large shar...